Literature DB >> 12959273

A comparative assessment of the duration of action of amlodipine and nifedipine GITS in normotensive subjects.

S Ueda1, P A Meredith, C A Howie, H L Elliott.   

Abstract

1 This study in normotensive subjects compared the duration and consistency of action of amlodipine (5 mg) and nifedipine GITS (60 mg) by assessment of the attenuation of pressor responses to noradrenaline and angiotensin II. 2 Both drugs significantly attenuated pressor responses to both vasoconstrictors at 6 and 24 h post-dose with rightward shifts of up to 2.3-fold in the dose-response curves. 3 There was significantly less pharmacokinetic variability with amlodipine: for example, intra-subject variability was 33% with amlodipine and 59% with nifedipine GITS. 4 There were no significant differences in the pressor dose ratios up to 48 h post-dose with amlodipine whereas there was a significant and progressive reduction in the pressor dose ratios with nifedipine. 5 These results suggest that both drugs are broadly comparable as once daily treatments but amlodipine displayed less intra- and inter-subject variability and provided a significantly more sustained effect with a reserve of pharmacological activity up to 48 h post-dose.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 12959273      PMCID: PMC1364661          DOI: 10.1111/j.1365-2125.1993.tb00415.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  19 in total

1.  Amlodipine: pharmacokinetic profile of a low-clearance calcium antagonist.

Authors:  D R Abernethy
Journal:  J Cardiovasc Pharmacol       Date:  1991       Impact factor: 3.105

2.  The first pass metabolism of nifedipine in man.

Authors:  D G Waller; A G Renwick; B S Gruchy; C F George
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

Review 3.  Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications.

Authors:  P H Stone; E M Antman; J E Muller; E Braunwald
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391

4.  Improved compliance measures: applications in an ambulatory hypertensive drug trial.

Authors:  P Rudd; S Ahmed; V Zachary; C Barton; D Bonduelle
Journal:  Clin Pharmacol Ther       Date:  1990-12       Impact factor: 6.875

5.  Compliance characteristics of 291 hypertensive patients from a rural midwest area.

Authors:  R B Widmer; R J Cadoret; E Troughton
Journal:  J Fam Pract       Date:  1983-10       Impact factor: 0.493

6.  Antihypertensive mechanism of amlodipine in essential hypertension: role of pressor reactivity to norepinephrine and angiotensin II.

Authors:  L Donati; F R Bühler; C Beretta-Piccoli; F Kusch; G Heinen
Journal:  Clin Pharmacol Ther       Date:  1992-07       Impact factor: 6.875

7.  Effect of calcium channel blockers on adrenergic and nonadrenergic vascular responses in man.

Authors:  F Pasanisi; H L Elliott; P A Meredith; D J Sumner; J L Reid
Journal:  J Cardiovasc Pharmacol       Date:  1985 Nov-Dec       Impact factor: 3.105

8.  Nifedipine and alpha adrenoceptor antagonism.

Authors:  M B Murphy; M J Brown; A J Scriven; D J Heavey; C T Dollery
Journal:  Clin Pharmacol Ther       Date:  1984-12       Impact factor: 6.875

9.  Effect of nifedipine on plasma renin, aldosterone and catecholamines in arterial hypertension.

Authors:  O L Pedersen; E Mikkelsen; N J Christensen; H J Kornerup; E B Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1979-05-21       Impact factor: 2.953

10.  Analysis of the pressor dose response.

Authors:  D J Sumner; H L Elliott; J L Reid
Journal:  Clin Pharmacol Ther       Date:  1982-10       Impact factor: 6.875

View more
  5 in total

1.  Trough/peak ratios for antihypertensive agents. The issues in perspective.

Authors:  P A Meredith
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

Review 2.  Clinical pharmacokinetics of nifedipine. Implications for the care of the elderly.

Authors:  H L Elliott; P A Meredith
Journal:  Drugs Aging       Date:  1997-12       Impact factor: 3.923

3.  Lacidipine: effects on vascular pressor responses throughout the dosage interval in normotensive subjects.

Authors:  S Ueda; R Donnelly; V Panfilov; A D Morris; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

Review 4.  Nifedipine gastrointestinal therapeutic system (GITS). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R N Brogden; D McTavish
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

5.  Patient compliance and therapeutic coverage: comparison of amlodipine and slow release nifedipine in the treatment of hypertension. The Belgian Collaborative Study Group.

Authors:  J M Detry; P Block; G De Backer; J P Degaute
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.